AAAAAA

   
Results: 1-18 |
Results: 18
COMPARISON OF 3 CYP2D6 PROBE SUBSTRATES AND GENOTYPE IN GHANAIANS, CHINESE AND CAUCASIANS
Authors: DROLL K BRUCEMENSAH K OTTON SV GAEDIGK A SELLERS EM TYNDALE RF
Citation: K. Droll et al., COMPARISON OF 3 CYP2D6 PROBE SUBSTRATES AND GENOTYPE IN GHANAIANS, CHINESE AND CAUCASIANS, Pharmacogenetics, 8(4), 1998, pp. 325-333
SIMULTANEOUS GAS-CHROMATOGRAPHIC DETERMINATION OF METHAMPHETAMINE, AMPHETAMINE AND THEIR P-HYDROXYLATED METABOLITES IN PLASMA AND URINE
Authors: CHEUNG S NOLTE H OTTON SV TYNDALE RF WU PH SELLERS EM
Citation: S. Cheung et al., SIMULTANEOUS GAS-CHROMATOGRAPHIC DETERMINATION OF METHAMPHETAMINE, AMPHETAMINE AND THEIR P-HYDROXYLATED METABOLITES IN PLASMA AND URINE, Journal of chromatography B. Biomedical sciences and applications, 690(1-2), 1997, pp. 77-87
EFFECT OF CYP2D1 INHIBITION ON THE BEHAVIORAL-EFFECTS OF D-AMPHETAMINE
Authors: TOMKINS DM OTTON SV JOHARCHI N BERNS T WU D CORRIGALL WA SELLERS EM
Citation: Dm. Tomkins et al., EFFECT OF CYP2D1 INHIBITION ON THE BEHAVIORAL-EFFECTS OF D-AMPHETAMINE, Behavioural pharmacology, 8(2-3), 1997, pp. 223-235
CYP2D6 INHIBITION IN PATIENTS TREATED WITH SERTRALINE
Authors: SPROULE BA OTTON SV CHEUNG SW ZHONG XH ROMACH MK SELLERS EM
Citation: Ba. Sproule et al., CYP2D6 INHIBITION IN PATIENTS TREATED WITH SERTRALINE, Journal of clinical psychopharmacology, 17(2), 1997, pp. 102-106
INHIBITION OF CYTOCHROME-P450 2D6 METABOLISM OF HYDROCODONE TO HYDROMORPHONE DOES NOT IMPORTANTLY AFFECT ABUSE LIABILITY
Authors: KAPLAN HL BUSTO UE BAYLON GJ CHEUNG SW OTTON SV SOMER G SELLERS EM
Citation: Hl. Kaplan et al., INHIBITION OF CYTOCHROME-P450 2D6 METABOLISM OF HYDROCODONE TO HYDROMORPHONE DOES NOT IMPORTANTLY AFFECT ABUSE LIABILITY, The Journal of pharmacology and experimental therapeutics, 281(1), 1997, pp. 103-108
EFFECT OF CYTOCHROME-P450 2D1 INHIBITION ON HYDROCODONE METABOLISM AND ITS BEHAVIORAL CONSEQUENCES IN RATS
Authors: TOMKINS DM OTTON SV JOHARCHI N LI NY BALSTER RF TYNDALE RF SELLERS EM
Citation: Dm. Tomkins et al., EFFECT OF CYTOCHROME-P450 2D1 INHIBITION ON HYDROCODONE METABOLISM AND ITS BEHAVIORAL CONSEQUENCES IN RATS, The Journal of pharmacology and experimental therapeutics, 280(3), 1997, pp. 1374-1382
INTERACTIONS OF AMPHETAMINE ANALOGS WITH HUMAN LIVER CYP2D6
Authors: WU DF OTTON SV INABA T KALOW W SELLERS EM
Citation: Df. Wu et al., INTERACTIONS OF AMPHETAMINE ANALOGS WITH HUMAN LIVER CYP2D6, Biochemical pharmacology, 53(11), 1997, pp. 1605-1612
VENLAFAXINE OXIDATION IN-VITRO IS CATALYZED BY CYP2D6
Authors: OTTON SV BALL SE CHEUNG SW INABA T RUDOLPH RL SELLERS EM
Citation: Sv. Otton et al., VENLAFAXINE OXIDATION IN-VITRO IS CATALYZED BY CYP2D6, British journal of clinical pharmacology, 41(2), 1996, pp. 149-156
DOES EXTENT OF P-HYDROXYLATION ALTER METHAMPHETAMINE KINETICS
Authors: OCAMPO JA BUSTO UE KAPLAN HL TYNDALE RF OTTON SV NOLTE H SYMANZIK C SELLERS EM
Citation: Ja. Ocampo et al., DOES EXTENT OF P-HYDROXYLATION ALTER METHAMPHETAMINE KINETICS, Clinical pharmacology and therapeutics, 59(2), 1996, pp. 83-83
BLOCKAGE OF THE BEHAVIORAL AND NEUROCHEMICAL EFFECTS OF HYDROCODONE BY QUININE ADMINISTRATION
Authors: GOMEZMANCILLA B CHEUNG S OTTON SV SELLERS EM
Citation: B. Gomezmancilla et al., BLOCKAGE OF THE BEHAVIORAL AND NEUROCHEMICAL EFFECTS OF HYDROCODONE BY QUININE ADMINISTRATION, The FASEB journal, 9(3), 1995, pp. 103-103
PHARMACOKINETICS OF DEXTROMETHORPHAN AND METABOLITES IN HUMANS - INFLUENCE OF THE CYPBDB PHENOTYPE AND QUINIDINE INHIBITION
Authors: SCHADEL M WU DA OTTON SV KALOW W SELLERS EM
Citation: M. Schadel et al., PHARMACOKINETICS OF DEXTROMETHORPHAN AND METABOLITES IN HUMANS - INFLUENCE OF THE CYPBDB PHENOTYPE AND QUINIDINE INHIBITION, Journal of clinical psychopharmacology, 15(4), 1995, pp. 263-269
EFFECTS OF ROUTE OF ADMINISTRATION ON DEXTROMETHORPHAN PHARMACOKINETICS AND BEHAVIORAL-RESPONSE IN THE RAT
Authors: WU DF OTTON SV KALOW W SELLERS EM
Citation: Df. Wu et al., EFFECTS OF ROUTE OF ADMINISTRATION ON DEXTROMETHORPHAN PHARMACOKINETICS AND BEHAVIORAL-RESPONSE IN THE RAT, The Journal of pharmacology and experimental therapeutics, 274(3), 1995, pp. 1431-1437
DOES SERTRALINE INHIBIT CYP2D6 AFTER CHRONIC DOSING
Authors: SPROULE BA OTTON SV CHEUNG SW ZONG XH ROMACH MK SELLERS EM
Citation: Ba. Sproule et al., DOES SERTRALINE INHIBIT CYP2D6 AFTER CHRONIC DOSING, Clinical pharmacology and therapeutics, 57(2), 1995, pp. 151-151
ABUSE AND DEPENDENCE ON PRESCRIPTION OPIATES
Authors: SPROULE BA BUSTO UE OTTON SV ZHONG XH SELLERS EM
Citation: Ba. Sproule et al., ABUSE AND DEPENDENCE ON PRESCRIPTION OPIATES, Clinical pharmacology and therapeutics, 57(2), 1995, pp. 162-162
COMPARATIVE INHIBITION OF THE POLYMORPHIC ENZYME CYP2D6 BY VENLAFAXINE (VF) AND OTHER 5HT UPTAKE INHIBITORS
Authors: OTTON SV BALL SE CHEUNG SW INABA T SELLERS EM
Citation: Sv. Otton et al., COMPARATIVE INHIBITION OF THE POLYMORPHIC ENZYME CYP2D6 BY VENLAFAXINE (VF) AND OTHER 5HT UPTAKE INHIBITORS, Clinical pharmacology and therapeutics, 55(2), 1994, pp. 141-141
HUMAN HEPATIC CYTOCHROME-P450 2D6-LIKE ACTIVITY IN NONHUMAN-PRIMATES - CATALYTIC CHARACTERIZATION IN-VITRO
Authors: WU DF OTTON SV MORROW P INABA T KALOW W SELLERS EM
Citation: Df. Wu et al., HUMAN HEPATIC CYTOCHROME-P450 2D6-LIKE ACTIVITY IN NONHUMAN-PRIMATES - CATALYTIC CHARACTERIZATION IN-VITRO, The Journal of pharmacology and experimental therapeutics, 266(2), 1993, pp. 715-719
CYP2D6 PHENOTYPE DETERMINES THE METABOLIC CONVERSION OF HYDROCODONE TO HYDROMORPHONE
Authors: OTTON SV SCHADEL M CHEUNG SW KAPLAN HL BUSTO UE SELLERS EM
Citation: Sv. Otton et al., CYP2D6 PHENOTYPE DETERMINES THE METABOLIC CONVERSION OF HYDROCODONE TO HYDROMORPHONE, Clinical pharmacology and therapeutics, 54(5), 1993, pp. 463-472
INHIBITION BY FLUOXETINE OF CYTOCHROME-P450 2D6 ACTIVITY
Authors: OTTON SV WU DF JOFFE RT CHEUNG SW SELLERS EM
Citation: Sv. Otton et al., INHIBITION BY FLUOXETINE OF CYTOCHROME-P450 2D6 ACTIVITY, Clinical pharmacology and therapeutics, 53(4), 1993, pp. 401-409
Risultati: 1-18 |